Table 2.
Average score (standard deviation) of nasal symptoms (NSS), of extra-nasal symptoms (ExNSS) and of peak nasal inspiratory flow (PNIF) of children with moderate/severe persistent allergic rhinitis at admission (V1) and after treatment (V2; 7 ± 2 days) with DP (desloratadine + prednisolone) or DB (dexchlorpheniramine + betamethasone).
| DP (n = 98) |
DB (n = 97) |
|||||
|---|---|---|---|---|---|---|
| V1 | V2 | V1 − V2 | V1 | V2 | V1 − V2 | |
| NSS | 8.9 (2.0) | 2.1 (2.3) | 6.8 | 9.1 (2.1) | 1.9 (2.3) | 7.2 |
| ExNSS | 5.7 (3.1) | 0.8 (1.2) | 4.9 | 5.3 (3.2) | 1.1 (2.2) | 4.2 |
| DP (n = 61) |
DB (n = 70) |
|||||
|---|---|---|---|---|---|---|
| V1 | V2 | V1 − V2 | V1 | V2 | V1 − V2 | |
| Peak nasal inspiratory flow (L/min) | ||||||
| PNIF | 70.3 (23.9) | 83.6 (26.3) | 13.3 | 64.5 (21.9) | 80.3 (25.0) | 15.8 |
Mann–Whitney.
NSS, ExNSS and PNIF-V1: DP = DB; V2: DP = DB; V1 − V2: DP = DB.
DP and DB–NSS, ExNSS and PNIF: V1 > V2 – p < 0.05.